Status:
COMPLETED
Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?
Lead Sponsor:
Norwegian University of Science and Technology
Conditions:
Headache
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
It is a common belief that patients with MOH rarely respond of preventative medications whilst overusing acute medications. However, no randomized trial has been done previously to prove such statemen...
Detailed Description
This randomized multi-centre study started January 2004, and patients with probably MOH have been included from five different University hospitals in Norway. The last patient was included November 9t...
Eligibility Criteria
Inclusion
- fulfill 8.2.7 probably medication-overuse headache according to the International Classification of Headache Disorders, 2th Edition (2004)
Exclusion
- No benefit of all available preventative medications
- no benefit of abrupt withdrawal lasting more than 3 weeks of acute medication that has been overused
- cluster headache
- chronic paroxysmal hemicrania
- hemicrania continua, pregnancy
- use of pain killers for other reasons than headache
- other reasons for chronic daily headache than medication-overuse
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00159588
Start Date
January 1 2004
End Date
December 1 2007
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Knut Hagen
Trondheim, Norway, 7006